Treatment for patients with a stromal tumor of the ovary

What we are studying

The purpose of this study is to find out whether treatment with the drugs paclitaxel and carboplatin work better to control your cancer than treatment with the drugs bleomycin, etoposide and cisplatin, which is the standard treatment for your type of cancer. Another purpose of this study is to find out what side effects are caused by treatment with these drug combinations. Another purpose of this study is to examine whether inhibin levels (a blood test) might be a good way to know how someone is responding to treatment. In this study you will get paclitaxel and carboplatin (considered the experimental therapy) or bleomycin, etoposide and cisplatin (considered the standard therapy). Additionally, more will be learned about this specific type of rare ovarian cancer by studying certain markers and substances.

Who is Eligible

  • Genders:
    • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 1+

Eligibility Criteria

  • Diagnosis of ovarian stromal tumor and no prior treatment with chemotherapy for your tumor.

What is involved

  • 1 screening visit
  • Receive 1 of 2 treatments (chosen at random) for at least 12 weeks
  • Follow-Up visits will be every 3 months for 2 years and then every 6 months for 3 years



Contact Information

Study Coordinator
Melissa Swain
[email protected]

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.